Literature DB >> 22715550

Pioglitazone and bladder cancer: the pros and cons.

Vijay Panikar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22715550

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN： 0004-5772


× No keyword cloud information.
  3 in total

1.  Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review.

Authors:  Saarwaani Vallabhajosyula; Shashaank Vallabhajosyula; Saraschandra Vallabhajosyula; Suma Nair; Asha Kamath; Karthik N Rao
Journal:  Med J Armed Forces India       Date:  2016-08-09

Review 2.  Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease.

Authors:  Sneha Kothari; Hiteshi Dhami-Shah; Samir R Shah
Journal:  J Clin Exp Hepatol       Date:  2019-06-27

3.  Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study.

Authors:  Sunil Gupta; Kavita Gupta; R Ravi; Vinita Mehta; Samar Banerjee; Shashank Joshi; Banshi Saboo
Journal:  Indian J Endocrinol Metab       Date:  2015 Sep-Oct
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.